Arbutus Biopharma Corporation ABUS

Full chart Compare
Set alert

Price alert · ABUS

All alert types
4.06 USD +0.18 (+4.64%)

At closeNov 4, 2026, 5:03 PM EST

4.06 0.00 0.00%

After hours · Nov 4, 5:03 PM ET

3.87 Day range 4.08
3.50 52-week range 5.45
YTD
-15.59%
1 year
-9.78%

Revenue & Expenses

Other Operating Income → Expenses: $363.00KExpenses → Selling, General & Admin: $15.89MExpenses → Research & Development: $25.24MExpenses → Interest Expense: $97.00KExpenses → Other Expenses: $6.35MGross Profit → Expenses: $13.72MRevenue → Gross Profit: $13.72MRevenue → Cost of Revenue: $363.00KNet Loss → Expenses: $33.50MOther Operating Income$363.00KGross Profit$13.72MNet Loss$33.50MCost of Revenue$363.00KExpenses$47.58MSelling, General & Admin$15.89MResearch & Development$25.24MInterest Expense$97.00KOther Expenses$6.35MRevenue$14.08M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

ABUS annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
14.08M6.17M18.14M39.02M10.99M
14.08M6.17M18.14M39.02M10.99M
14.08M6.17M18.14M39.02M10.99M
54.07M79.86M96.17M102.24M82.64M
25.24M54.04M73.70M84.41M65.50M
15.89M22.11M22.48M17.83M17.14M
-39.99M-73.69M-78.03M-63.22M-71.65M
97.00K137.00K459.00K1.73M2.86M
-33.50M-69.92M-72.85M-69.46M-76.25M
-33.50M-69.92M-72.85M-69.46M-88.39M
-33.50M-69.92M-72.85M-69.46M-88.39M
-33.50M-69.92M-72.85M-69.46M-76.25M
-0.17-0.38-0.44-0.46-0.83
-0.17-0.38-0.44-0.46-0.83
-0.17-0.38-0.44-0.46-0.83
-33.40M-69.78M-72.39M-63.29M-73.39M
-33.40M-69.78M-72.39M-63.29M-73.39M
191.60M185.61M165.96M150.94M106.24M
191.60M185.61M165.96M150.94M106.24M